Editor’s Note: The bulk of Heather Zeiger’s study in bioethics has focused on the major issues addressed in American media, politics and science, such as stem cells, cloning and euthanasia, which is why she so anticipated this year’s theme for the Center for Bioethics and Human Dignity Conference: Global Bioethics. The global context brought a broader perspective on the issues surrounding bioethics: India’s medical tourism and black market organ donations, treating AIDS/HIV in Africa with limited resources, and euthanasia laws in Australia. One country that has been at the forefront of bioethics news is Great Britain because of their lenient legislation on issues concerning human dignity and “human exceptionalism” (the idea that humans have a higher moral status than any other species). This is the first article emerging from her studies and experience at the Global Bioethics conference.

Dr. Calum MacKellar of the Scottish Council on Human Bioethics, who has represented Scotland at the Council of Europe and UNESCO, discussed human/animal hybrids, which can be legally created for research purposes in Great Britain. This article reports the major points of Dr. MacKellar’s lecture and unless otherwise noted, all facts and statistics are drawn from his extended report on the Scottish Council on Human Bioethics Web site (www.schb.org.uk).

What Are Hybrids? What Are the Possibilities?

True Hybrids are embryos formed when the gametes (egg and sperm) are from different species. For example a human/chimp hybrid would be formed from the combining of a human egg with a chimpanzee sperm, or vice versa. These true hybrids create a new entity or species. One familiar example brought about by breeding is a mule, which is produced from horse and donkey gametes. In nature animal/animal hybrids tend to be less fit than their parents. Experiments to combine human and animal gametes have not been successful.

Cybrids are formed when the nucleus of an egg from one species is removed and filled with the nuclear material of another species. This mimics the technology of cloning, except one is using nuclear material from one species and a cell from a different species. The term cybrid comes from the combination of “cytoplasmic hybrid” because the genetic material in this new embryo is 99.9% of the nuclear species and 0.01% of the species that donated the egg [Michael Cook, “Soft Cell: How Scientists Are Easing away Opposition to Animal-Human Hybrids” Salvo, Issue 4, Winter 2009]. Most genetic material is found in the nucleus, but a little bit is left in the cytoplasm of the egg. Scientists have been able to insert human genetics (a nucleus) into a cow’s egg (an enucleated egg). The resulting embryo survived for twelve days. Other experiments have involved inserting human genetic material into a frog’s egg and into a rabbit’s egg. Neither of these survived beyond a week and never reached the blastocyst stage.

Chimeras (kī-‘mir-uhz) are formed when the cells of one species are added to the embryo of another species. This results in an animal that has distinct parts from one species or the other. Think of the centaur in fantasy fiction. Fictional centaurs exhibit distinct parts that are human and distinct parts that are horse. This has actually been done in the lab with a goat and sheep. The resulting animal did survive and had distinctive goat legs and a distinctive sheep head.

Transgenic embryos are created by adding a few genes from one species into the embryo of another species. However, only a few genes can be added before the embryo collapses, providing self-limitations for this technique. Scientists have inserted human genes into pigs to create human insulin for diabetes patients. Scientists have also attempted to replace damaged human heart valves with animal heart valves. This is using animal parts in a mechanistic sense, and is known as xenotransplantation.

Although the media and legislation discuss human/animal hybrids, they are really talking about human/animal cybrids. While there are examples of hybrids in nature, thus far all experiments with human/animal hybrids have proven unsuccessful, even using in vitro fertilization technology.

Is This Legal?

Very few countries have passed specific legislation pertaining to any kind of combination of human and non-human material. Most laws either single out humans or animals. However, several recent initiatives have been discussed:

• Council of Europe: Embryonic, Foetal and Post-natal Animal-Human Mixtures, Doc. 10716 (October 11, 2005)—This document encourages the participating states to consider the ethical ramifications of creating human/animal hybrids, and also encourages the formation of a steering committee within the Council of Europe to address these ethical issues.

• Canada: Assisted Human Reproduction Act 2004 —This act prohibits the creation of a chimera or a hybrid and prohibits the transfer of a chimera or hybrid into a human being or a non-human life form.

• USA: Draft Human Chimera Prohibition Act of 2005 (S.1373) —This draft, introduced by Senator Sam Brownback, would prohibit “any person to knowingly, in or otherwise affecting interstate commerce: (1) create or attempt to create a human chimera; (2) transfer or attempt to transfer a human embryo into a non-human womb; (3) transfer or attempt to transfer a non-human embryo into a human womb; or (4) transport or receive for any purpose a human chimera.” In this case, some hybrids would fall under the category of chimera.

• United Kingdom: Human Fertilisation and Embryology Act (1990)—This legislation states that the creation of human/animal entities would exist in a “legal vacuum” and hybrids could be formed if a proper license is obtained. The importance of this act is the fact that it makes it unclear whether the human/animal entities fall under human or animal legislation.

What Are the Consequences of Using This Technology?

Legal Consequences

There are several legal issues to consider, but probably the most troubling is whether the entity produced should fall under human or animal legislation. Several questions follow this, such as “What percentage of the being needs to be human to fall under human legislation? What if the human/animal entity began as 30% human and 70% animal, but the human cells grew faster and the entity ended up being 70% human and 30% animal?” Dr. MacKellar preferred erring on the side of caution and giving the entity the protection and dignity entitled to a human being, however this is only a protective declaration and does not solve the myriad legal issues surrounding the creation of this new entity.

Societal Consequences

The formation of an entity that is both animal and human raises questions of personhood and challenges our definition of humanness. These beings will inevitably be met with challenges that go beyond identification with a minority group. Would protections such as the Fourteenth Amendment apply to these creatures, and how human would they have to be for them to possess rights and privileges? Would society want to grant them rights and privileges? Would the military want to create a human/ape hybrid soldier in hopes that they would be bigger, stronger, and easier to feed? Given human history, the temptation to relegate these beings to a lower class would be inevitable.

There are risks associated with diseases that may cross the species barrier. As Dr. MacKellar pointed out, we have several examples of diseases crossing the species barrier including HIV, swine flu and bird flu. We also know that these diseases can sometimes be more harmful or even fatal to one species than they were to another. If an entity is part human and part animal, and a disease is very contagious among either type of animal it shares characteristics with, it will likely infect the hybrid. At this point, the disease may adapt to human DNA, posing a great health threat to all humans, not just hybrids.

Do Hybrids and Cybrids Have Souls?

I believe, from a biblical perspective, the creation of hybrids, cybrids, and chimeras is unethical. However, some instances of transgenic technology, namely xenotransplantation, may be ethical, especially since there are built-in biological limitations regarding how many genes can be inserted into another species.

Do these procedures violate the sanctity of human life? Several thoughts:

• Humans are created in God’s image (Gen 1:26);

• We were created separately (Gen 1:25, 26). We were created differently than the animals (“Let the earth bring forth living creatures…” Gen 1:24; “then the Lord God formed the man of dust from the ground and breathed into his nostrils the breath of life, and the man became a living creature” Gen 2:7);

• We humans were given dominion over the animals (Gen 1:29, 30). Therefore, these procedures do seem to violate the sanctity of human life as revealed in Scripture.

Are scientists attempting to bridge the gap in created kinds?

God directly created animals according to their kind, and it is implied in the flood account that He intended for them to reproduce according to their kind (Gen. 1:21; Gen. 8:17).

The Bible indicates that man has dignity and worth. If we try to create a being that might be less-than-human by combining it with animal cells or gametes, this would diminish such God-given qualities. It is from a naturalistic perspective that people believe animals are better than man because they seem to be stronger, faster, or heartier. This is not the Biblical perspective.

Do these procedures have something in common with bestiality?

One could argue that the creation of human/animal hybrids may constitute an instance of bestiality. Biblically, bestiality is a type of fornication with animals; it is a type of intimacy that perverts the real intimacy that God designed between a husband and wife. I find bestiality to be a particularly distasteful subject, and perhaps we get an indication of God’s distaste for this since it is a sin that was punishable by death (Ex. 22:19; Lev. 18:23; Lev. 20:15, 16; Deut. 27:21). Procreation and consummation are not distinctly separate in the Bible. It is only through modern technology that procreation can occur in the laboratory apart from consummation. I think an argument could be made that procreation with human and animal gametes is a connection with animals that man was not meant to experience.

But what about…?

This article is a short report on hybrids and variations on combining human and non-human species, but we have not even discussed the multiple questions that arise from this type of experiment, such as:

• Why are scientists doing this?

• What are the implications for common descent if human and animals can breed?

• How does this affect the definition of species?

Also, I did not really deal with whether hybrids have souls or not because we just don’t know. Personally, I think it will be biologically impossible to create a true human/animal hybrid, but cybrids may be a possibility. I think that, much like clones, a cybrid that grows beyond the embryonic stage would be very unstable and unhealthy as well as incredibly expensive and inefficient to make. And much like clones, I can’t answer if they would have a soul.

I am thankful for groups like the Scottish Council on Human Bioethics for addressing this topic in secular language within the public square, but with an underlying Biblical perspective. It is groups like this that enable us to interact in a well-informed way in our places of influence. Whether it is voting for legislation or simply talking with our friends at Starbucks, you don’t have to work for the Council of Europe to champion the Biblical perspective within the public square.

You can find Dr. MacKeller’s full report on the Scottish Council of Human Bioethics Web site: www.schb.org.uk.

© 2009 Probe Ministries

As far as dramas go, the stem cell saga contains all the elements of a juicy prime-time soap opera. The excitement, the promises, the characters, the politics, the lies, the scandal, the moneythe only thing missing is sex, but thats the point, isnt it?

On November 20, 2007, the journals Science and Cell announced a truly major discovery. It was a way to convert human skin cells taken from a simple skin biopsy into stem cells that behave like an embryonic stem cellbut the byproduct is not an embryo and can in no way become one.{1} This has the effect, say many, of sidestepping the ethically troublesome practice of creating then destroying human embryos in order to treat diseases.

This new method is efficient. One biopsy can produce 20 stem cell lines, and can be taken from the patient himself, eliminating the risks associated with tissue rejection. We hear about stem cell breakthroughs all the time; how is this one different? Is this method ethical? Will it save as many lives as embryonic stem cells promise to? Is this the end of the stem cell controversy?

The Saga

Stem cells are simply cells that make other cells. Their job is to be a cell factory. By analogy, think of a rose. From the stem of the rose grows leaves, the flower, and thorns. The thorns dont produce flowers, the leaves dont produce thorns, and the flower doesnt produce leaves, but the stem does. The stem is versatile; it can make many parts of the plant. Stem cells operate the same way. Some stem cells are more versatile than others. In other words, some stem cells can make many types of cells and others can only make one type of cell.

The history of embryonic stem cells dates back to the 1950s when two scientists isolated a teratoma from a mouse. A teratoma is a tumor that is composed of various types of cells from hair cells to eye cells to teeth to nails, so the scientists aptly named it a teratoma, or monster. When investigating this tumor, the scientists found that the stem cells that produced this array of cell types had very similar properties of embryonic cells. Thus began the investigation into embryonic stem cells.{2}

Before the term stem cells had become popular, bone marrow transplants had been used to treat patients with leukemia. Whenever a patient receives a bone marrow transplant from a donor, they are really receiving a type of stem cell therapy. At this point, scientists could only use bone marrow stem cells for very specific cell replacement. These stem cells were not very versatileat least that was the theory at the time. Since then, bone marrow stem cells have been found to be quite versatile, and can be coaxed into becoming a variety of cells. Scientists have now found a variety of adult stem cells throughout the body and have been using them in humans to cure or alleviate a number of diseases or conditions (see www.stemcellresearch.org for a complete list).

Another breakthrough with stem cells arose from tissues such as umbilical cord blood, placental tissue, amniotic fluid and even menstrual bloodall obtained without harming the life of the baby at any stage of development. Each of these stem cells are a little more versatile than the adult stem cells, meaning that they can become two or three different types of cells, and in many cases the donor/recipient need not be an exact match. The National Cord Blood Program is just one group that allows parents to put their babys umbilical cord blood in a bank so that he or she could use it for therapy sometime in the future, or they can donate the umbilical cord for others to use. See www.nationalcordbloodprogram.org for a list of patient success stories.{3}

If these are adult stem cells, then what are embryonic stem cells? These are cells removed from the eight-day-old embryo. When these cells are removed, the embryo dies. These cells produce almost all of the cells in the human body, and therefore are the most versatile stem cells. You may have heard of these cells as being pluripotent. That simply means that they are very versatile. Some scientists believed that embryonic stem cells (ESC) research was where time, money and resources should go since we know that these cells have the potential to become any cell type.

Numerous success stories of treatments with adult stem cells have been under-reported by the media, while the supposedly cure-all ESC were hypedeven though they have shown no actual success in humans. Ironically, adult stem cells have been saving patients lives for years (bone marrow transplants), while ESC scientists have yet to control the growth rate of the ESC. In what shouldnt be a surprise to anyone, ESC tended to form grotesque tumors (teratomas) composed of various cells found in the body.

Debate over the ethics of using embryos became heated within the political arena. The individuality and dignity of the embryo came into question. Scientists wanted unfettered research{4} so that all options can be explored to cure diseases, while others considered the embryo a very vulnerable life that has the right to be protected from experimentation. Both sides claimed to be arguing for the good of humanity.

These debates, however, have taken a slightly different turn with the recent discovery of converting skin cells into pluripotent stem cells mentioned above.

Skin Cells

As mentioned, now scientists have isolated human stem cells that are as versatile as embryonic stem cells, but no embryos were used to obtain these stem cells. While more studies are needed to confirm that these cells act like ESCs in the human body, they behave just like ESCs in the lab.

There are a few concerns with this procedure. One of the biggest concerns is the way these stem cells are made. Both research groups had to use a type of virus to insert the right code into the skin cells to tell it to become a stem cell. This virus may be harmful to humans. However, both scientists are researching safer methods for coaxing the skin cells into stem cells.{5}

So is this method ethical? I strongly believe the answer is yes. As Leon Kass, former head of the Presidents Council on Bioethics, stated in a National Review Online symposium, Reprogramming of human somatic cells to pluripotency is an enormously significant achievement, one that boosters of medical progress and defenders of human dignity can celebrate without qualification.{6} Sanctity of life advocates can celebrate because no embryos are created or destroyed for research.

Both scientists who first published on this new discovery, Dr. James A. Thomson from the U.S. and Dr. Shinya Yamanaka from Japan, said that this research could not have been done without the knowledge that we already had from embryonic stem cells. And Thomson, who was one of the first scientists to remove a stem cell from a human embryo,{7} has specifically stated that embryonic stem cell research should continue.{8} We must keep this point in mind, but we must also remember that, contrary to what some in the scientific community are saying, both scientists had more than just economic reservations about using embryos in their research:

Thomson: If human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought about it enoughI thought long and hard about whether I would do it.{9}

 

Yamanaka: When I saw the embryos, I suddenly realized there was such a small difference between it and my daughtersI thought, we cant keep destroying embryos for our research. There must be another way.{10}

Is This Match Point?

Most people agree that this changes the political and scientific culture of the stem cell debate. Surprisingly, some major players have come around.

Jose Cibelli, research scientist whose successful primate cloning was overshadowed by the skin cell announcement states, If their method is as good as the oocyte (the cell that forms a human egg)we will be no longer in need of the oocytes, and the whole field is going to completely change. People working on ethics will have to find something new to worry about.{11} Even Ian Wilmut, the scientist famous for creating Dolly the Sheep [see Probe article], decided to abandon cloning and work with reprogramming cells instead. As the Britains Telegraph reports, The scientist who created Dolly the sheep, a breakthrough that provoked headlines around the world a decade ago, is to abandon the cloning technique he pioneered to create her. I decided a few weeks ago not to pursue nuclear transfer, Prof Wilmut said.{12}

Several of the participants of National Review Online Symposium agree that this removes the ethical concerns from researching pluripotent cells, and, pragmatically, this seems to be significantly more efficient than cloning embryos to remove stem cells. Case closed? Not quite.

Not all agree that this is the end of using embryos to extract stem cells. As Wesley Smith, bioethicist, vocal ESC critic and Discovery Institute fellow, points out on his blog, www.bioethics.com:

If anyone thought that the pro-human cloners would fold up their tents and steal away after the news was released that patient-specific, pluripotent stem cells had been derived from normal skin cells, they just dont understand how fervently some scientists and their camp followers want to clone human lifeand how hopeful some are that the stem cell issue can be the vehicle that wins the culture war.{13}

Recall that we are dealing with scientists careers and, for the most part, scientists with a utilitarian worldview. A scientist whose worldview is dictated by whatever is for the greater good and has built his entire career and reputation around embryonic stem cell research is not going to readily abandon it. To see the interplay of both career and worldview choices, Dr. Hans Keirstead, neurobiologist and stem cell researcher at the University of California-Irvine, had this to say in an interview for the Arizona Daily Star:

I do think a great deal of this work could be done with the skin-cell derived stem cells. But wed have to start completely over, from scratch, and we are not going to slow down to do that, not at this point.

It is my personal feeling its a very ethical decision to use this tissue [Embryonic Stem Cells] to end human suffering, to better human life, than to destroy it.{14}

Conclusion:

As Christians, we operate within an ethical framework dictated by Gods word. Although the Bible does not mention stem cells, it does make clear that we are made in Gods image (Genesis 1:26, 27), that God knew us and knit us together within our mothers womb (Psalm 139: 13-16), and how God called prophets before they were even born (Isaiah 49:1; Jeremiah 1:4-5). God values the life of the unborn. We do not always have the privilege of seeing ethical decisions vindicated in our lifetime, but we can be confident that God is sovereign over all things.

Notes:

1. Takahashi, Kazutoshi, et al, Cell 131, 861-872, November 30, 2007; Yu, Junying, et al Sciencexpress, www.sciencexpress.org, (fee/registration to access full article) November 20, 2007.
2. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research Solter, Davor Nature Reviews 326, vol. 7, April 2006.
3. See list of references from Family Research Council, www.frc.org/get.cfm?i=IS06H01. See also www.stemcellresearch.org/facts/asc-refs.pdf for a sampling of peer reviewed research articles.
4. This case history [of ESC research] again reinforces the old truism that unfettered basic research driven only by scientific curiosity is usually the best way to discover things of enormous practical value Solter, Davor Nature Reviews 326, vol. 7, April 2006.
5. Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo analysis by Maureen Condic, Ph.D. from www.stemcellresearch.org/statement/pptalkingpointsweb.pdf.
6. National Review Online NRO Symposium, nationalreview.com, Brave New Future.
7. Thompson, James A. et al, Science 282, 1998.
8. Standing in the Way of Stem Cell Research by Alan I. Leshner and James A. Thomson Washington Post, 12-0-07, pg. A17.
9. Man Who Helped Start the Stem Cell War May End It by Gina Kolata, New York Times, Nov. 22, 2007.
10. Risk Taking Is in His Genes by Martin Fackler, New York Times, 12-11-07.
11. Vogel, Gretchen, and Holden, Constance , Field Leaps Forward with New Stem Cell Advances Science 318, 23 November 2007, p. 1224.
12. Dolly creator Prof Ian Wilmut shuns cloning by Roger Highfield, Telegraph 11/16/07, www.telegraph.co.uk.
13. ‘Lead Into Gold:’ Stem Cell Counter-Attack by Wesley Smith. Posting for November 27, 2007 www.bioethics.com.
14. Human embryonic stem-cell work must go on, says researcher by Carla McClain, Arizona Daily Star, 11-28-2007.

 

 

© 2007 Probe Ministries

What Are Stem Cells and Why Are They Important?

President Bush recently decided to allow the use of federal funds to research the therapeutic properties of privately produced human embryonic stem cells (ES). President Bush clearly maintained the prohibited use of federal monies to produce human ES cells, since the procedure requires the destruction of the embryo to obtain them, which is currently prohibited by federal law. To fully understand the ramifications of this decision, I will discuss the nature of stem cells and their potential to treat disease.

Most of the more than one trillion cells that form the tissues of our bodies possess a limited potential to reproduce. If you remove some live human skin cells, they may divide in culture (laboratory conditions) five or six times and then die. Special cells in the underlying skin layers are what produce new skin cells. These cells’ sole function is to churn out replacement cells. These are known as stem cells. Most tissues of our bodies possess stem cells that can reproduce the different cells required in that tissue. Bone marrow stem cells can produce the many different cells of the blood. They are called stem cells, since they are seen as the stem of a plant that produces all the “branches and leaves” of that tissue.

What I’ve described is referred to as adult stem cells. There is no controversy revolving around the use of human adult stem cells in research, since they can be retrieved from the individual requiring the therapy. The promise of adult stem cells has increased dramatically in recent years. Stem cells have even been found in tissues previously thought to be devoid of them, such as neural tissue. It has recently been shown that certain types of stem cells are not limited to producing cells for the tissue in which they reside. For instance, bone marrow stem cells can produce skeletal muscle, neural, cardiac muscle, and liver cells. Bone marrow stem cells can even migrate to these tissues via the circulatory system in response to tissue damage and begin producing cells of the appropriate tissue type.{1}

In addition to the advantages of previously unknown adult stem cells and their unexpected ability to produce numerous types of cells, adult stem cells carry the added potential of not causing any immune complications. Conceivably adult stem cells could be harvested from the individual needing the therapy, grown in culture to increase their number, and then be reinserted back into the same individual. This means the treatment could be carried out with the patient’s own cells, virtually eliminating any rejection problems. Adult stem cells may also be easier to control since they already possess the ability to produce the needed cells simply by being placed in the vicinity of the damaged tissue.

Human Embryonic Stem Cells

The advances in adult stem cell research has only come about in the last three years. Traditionally it was thought that ES cells carried the greatest potential to treat wide-ranging degenerative diseases such as diabetes, Parkinson’s, multiple sclerosis, spinal chord injuries, and Alzheimer’s. Since ES cells derive from the inner cell mass of the early embryo (5-7 day old blastocyst), they are capable of forming all the tissues of the body. Therefore, researchers have long felt that human ES cells hold the greatest potential for treatment of degenerative diseases.

While the potential has always existed, the problem has been that in order to obtain these human ES cells, the embryo is destroyed during the harvesting procedure. In addition, while ES cells had been obtained and grown successfully in culture from several mammals, including mice, efforts at producing ES cells from other mammals had failed. Nobody was sure human ES cells could even be successfully produced until November 1998 when James Thomson from the University of Wisconsin announced the establishment of five independent human ES cell lines.{2} (A cell line is a population of cells grown from a single cell that has been manipulated to continue growing indefinitely in culture, while maintaining its cellular integrity.) Geron Corporation funded Thomson’s work, so it did not violate the federal ban on government funds being used for such purposes. But his announcement immediately opened up a desire by federally funded researchers to use his already established human ES cells.

But there are potential problems and uncertainties in both adult and ES cells. While the ethical difficulties are non-existent for adult stem cells, they may not prove as helpful as ES cells. ES cells have the potential for universal application, but this may not be realized. As stated earlier, establishing ES cell lines requires destruction of human embryos. An ethical quagmire is unavoidable.

Whereas adult stem cells can be coaxed into producing the needed cells by proximity to the right tissue, the cues needed to get ES cells to produce the desired cells is not known yet. Some in the biotech industry estimate that we may be twenty years away from developing commercially available treatments using ES cells.{3} Clinical trials using adult stem cells in humans are already under way.

In August of 2000, NIH announced new guidelines allowing federally funded researchers access to human ES cell lines produced through private funding. The Clinton administration hailed the new guidelines, but Congressional pro-life advocates vowed a legal confrontation claiming the new guidelines were illegal.

The Options for President Bush

This was the situation facing President Bush when he took office. The pressure to open up federally funded human ES cell research mounted from patient advocacy groups for diabetes, spinal chord injuries, Parkinson’s disease, and Alzheimer’s. Additional pressure to reject federal funding of human ES cell research came from traditional pro-life groups including National Right to Life and the Catholic Church, with personal lobbying from Pope John Paul II.

One option open to the President and advocated by the scientific community was to free up all research avenues to fully explore all possibilities from ES cells regardless of their source. This would include federal funding for ES cells derived from embryos specifically created for this purpose. Few openly advocated this, but the oldest fertility clinic in the U. S. (in Virginia) announced recently that they were doing just that. Few within the government or research communities offered much protest.

Another option on the opposite end of the spectrum would have been to not only prohibit all federal funding on the creation and use of ES cells, but to also propose a law which would effectively ban all such research in the U. S., regardless of the funding source. Because of my view of the sanctity of human life from the moment of conception, this would be the ideal solution. However, this is not practical, since Roe v. Wade still is the rule of law in the U. S. This means that by law, a mother can choose to do with her embryo whatever she wants. If she wishes to end its life by abortion or by donation for research as a source of ES cells, she is free to do so.

A third option open to the President, and the one advocated by most in the research community, was to open up federal funding for the use and creation of ES cells derived from leftover embryos destined for destruction at fertility clinics. Some have estimated that there are over 100,000 such embryos in frozen storage in the U. S. alone. The intent is to find some use or ascribe some value to these leftover embryos. It is common practice in fertility clinics to fertilize 8-9 eggs at a time to hedge your bet against failure and to minimize expenses. As many as half of these embryos are left over after a successful pregnancy is achieved. These embryos are either left in frozen storage or destroyed at the request of the parents. So why not use them for research?

Other Options Available to President Bush

Advocates for ES cell research argue that if the embryos left over from infertility clinics are going to be wasted anyway, why not put them to some use and allow their lives to be spent helping to save someone else? The first mistake was to generate extra embryos without a clear intent to use all of them or give them up for adoption. Second, these tiny embryos are already of infinite value to God. We’re not going to redeem them by killing them for research. Each embryo is a unique human being with the full potential to develop into an adult. Each of us is a former embryo. We are not former sperm cells or egg cells.

Third, this is essentially using the dangerous ethical maxim that “the end justifies the means.” A noble end or purpose does not justify the crime. Just because a bank robber wants to donate all the money to charity doesn’t make the bank heist right. Nazi researchers gained valuable information through their many life- threatening experiments on Jews and other “undesirables” in the concentration camps of WWII. But most would not dignify these experiments by examining and using their findings.

A fourth option that I prefer is to close off all federal funding for human ES cell research. This would allow private dollars to fund human ES cell research, and federal dollars can be used to vigorously pursue the ethically preferable alternative offered by adult stem cells, which have shown great promise of late.

This would undoubtedly slow the progress on human ES cells and some researchers. Because of their dependence on federal research grants, they would not be able to pursue this line of research. But nowhere is it written that scientists have a right to pursue whatever research goals they conceive as long as they see a benefit to it. For years the U. S. Congress passed the Hyde Amendment that prohibited the use of federal funds for abortions, even though abortions were legal. The creation of human ES cells may be legal in the U. S. but that doesn’t mean researchers have a right to government monies to do so.

The President did decide to allow the use of federal funds only for research involving the 60 already existing human ES cell lines. The President expressly prohibited the use of government dollars to create new ES cell lines, even from leftover embryos. Researchers and patient advocates are unhappy, because this will limit the available research if these already existing ES cell lines don’t work out. Pro-life groups are unhappy, because the decision implicitly approves of the destruction of the embryos used to create these ES cell lines.

Stem Cells in the News Since the President’s Decision

When the President decided to open up federal funding for research on already existing human embryonic stem cell lines, just about everybody was unhappy. Researchers and patient advocates were unhappy, because this will limit the available research if these already existing cell lines don’t work out. The supply just might not meet the research demand. Pro-life groups were unhappy, including myself, because the decision implicitly approves of the destruction of the embryos used to create these ES cell lines. They will cost researchers at least $5,000 per cell line. Therefore, to purchase them for research indirectly supports their creation. Since both sides are unhappy, it was probably a good political decision even if it was not the right decision.

We certainly haven’t heard the end of this debate. Members of Congress are already positioning to strengthen or weaken the ban by law. Either way, the policy of the United States has clearly stated that innocent human life can be sacrificed without its consent, if the common good is deemed significant enough to warrant its destruction. I fully believe that this is a dangerous precedent that we will come to regret, if not now, then decades into the future. The long predicted ethical slippery slope from the abortion decision continues to threaten and gobble up the weak, the voiceless, and the defenseless of our society.

What has alarmed me the most since the President’s decision is the full assault in the media by scientists to gain even greater access to more human embryonic stem cells, regardless of how they are produced. The ethical question virtually dropped from the radar screen as scientists debated whether the existing cell lines would be enough.

This attitude is reflected in the increasing attention given to potential benefits, while downplaying the setbacks and problems. The scientists speaking through the media emphasize the new therapies as if they are only a few years down the road. The more likely scenario is that they are decades away. Your grandmother isn’t likely to be helped by this research.

Virtually nobody knows about the failure of human fetal cells to reverse the effects of Parkinson’s disease in adults. About 15 percent of patients from a recent trial were left with uncontrollable writhing and jerking movements that appear irreversible. The others in the study weren’t helped at all.{4} Chinese scientists implanted human embryonic stem cells into a suffering Parkinson’s patient’s brain only to have them transform into a powerful tumor that eventually killed him.{5}

Research with mouse embryonic stem cells has not faired much better. Scientists from the University of Wisconsin recently announced success in tricking human embryonic stem cells into forming blood cell-producing stem cells. Enthusiastic claims of future therapies overshadowed the reality that the same procedure has been successful in mice, except that when these cells are transplanted into mice, nothing happens. They don’t start producing blood cells and nobody knows why.{6}

This debate will continue. Stay tuned.

Notes

1. H. M. Blau, T. R. Brazelton, and J. M. Weiman, 2001, “The evolving concept of a stem cell:entity or function,” Cell Vol. 105 (June 29, 2001), p. 829-841.

2. James A. Thomson, et al., 1998, “Embryonic stem cell lines derived from human blastocysts.” Science Vol. 282 (November 6, 1998): 1145-1147. Also in same issue see Perspective article by John Gearhart, “New potential for human embryonic stem cells,” p. 1061-1062.

3. David Hamilton and Antonio Regaldo, 2001, “Biotech industry – unfettered, but possibly unfilfulled,” Wall Street Journal, August 13, 2001, p. B1.

4. Tracy Maddox, 2001, Fetal tissue fails to cure Parkinson’s patients. http://www.pointofview.net/ar_fetal.html. 3/21/01.

5. Charles Krauthammer, 2001, “The great stem cell hoax,” The Weekly Standard, August 20/August 27, 2001, p. 12

6. Nicholas Wade, 2001, “Blood cells from stem cells,” Dallas Morning News, September 4, 2001, p. A1. The article was a New York Times News Service report.

©2001 Probe Ministries

Dr. Ray Bohlin explains stem cells and where they come from, insisting the potential of stem cell therapy must be weighed against the personhood of the embryo.

What Are Stem Cells and Why Are They Important?

President Bush recently decided to allow the use of federal funds to research the therapeutic properties of privately produced human embryonic stem cells (ES). President Bush clearly maintained the prohibited use of federal monies to produce human ES cells, since the procedure requires the destruction of the embryo to obtain them, which is currently prohibited by federal law. To fully understand the ramifications of this decision, I will discuss the nature of stem cells and their potential to treat disease.

Most of the more than one trillion cells that form the tissues of our bodies possess a limited potential to reproduce. If you remove some live human skin cells, they may divide in culture (laboratory conditions) five or six times and then die. Special cells in the underlying skin layers are what produce new skin cells. These cells’ sole function is to churn out replacement cells. These are known as stem cells. Most tissues of our bodies possess stem cells that can reproduce the different cells required in that tissue. Bone marrow stem cells can produce the many different cells of the blood. They are called stem cells, since they are seen as the stem of a plant that produces all the “branches and leaves” of that tissue.

What I’ve described is referred to as adult stem cells. There is no controversy revolving around the use of human adult stem cells in research, since they can be retrieved from the individual requiring the therapy. The promise of adult stem cells has increased dramatically in recent years. Stem cells have even been found in tissues previously thought to be devoid of them, such as neural tissue. It has recently been shown that certain types of stem cells are not limited to producing cells for the tissue in which they reside. For instance, bone marrow stem cells can produce skeletal muscle, neural, cardiac muscle, and liver cells. Bone marrow stem cells can even migrate to these tissues via the circulatory system in response to tissue damage and begin producing cells of the appropriate tissue type.{1}

In addition to the advantages of previously unknown adult stem cells and their unexpected ability to produce numerous types of cells, adult stem cells carry the added potential of not causing any immune complications. Conceivably adult stem cells could be harvested from the individual needing the therapy, grown in culture to increase their number, and then be reinserted back into the same individual. This means the treatment could be carried out with the patient’s own cells, virtually eliminating any rejection problems. Adult stem cells may also be easier to control since they already possess the ability to produce the needed cells simply by being placed in the vicinity of the damaged tissue.

Human Embryonic Stem Cells

The advances in adult stem cell research has only come about in the last three years. Traditionally it was thought that ES cells carried the greatest potential to treat wide-ranging degenerative diseases such as diabetes, Parkinson’s, multiple sclerosis, spinal chord injuries, and Alzheimer’s. Since ES cells derive from the inner cell mass of the early embryo (5-7 day old blastocyst), they are capable of forming all the tissues of the body. Therefore, researchers have long felt that human ES cells hold the greatest potential for treatment of degenerative diseases.

While the potential has always existed, the problem has been that in order to obtain these human ES cells, the embryo is destroyed during the harvesting procedure. In addition, while ES cells had been obtained and grown successfully in culture from several mammals, including mice, efforts at producing ES cells from other mammals had failed. Nobody was sure human ES cells could even be successfully produced until November 1998 when James Thomson from the University of Wisconsin announced the establishment of five independent human ES cell lines.{2} (A cell line is a population of cells grown from a single cell that has been manipulated to continue growing indefinitely in culture, while maintaining its cellular integrity.) Geron Corporation funded Thomson’s work, so it did not violate the federal ban on government funds being used for such purposes. But his announcement immediately opened up a desire by federally funded researchers to use his already established human ES cells.

But there are potential problems and uncertainties in both adult and ES cells. While the ethical difficulties are non-existent for adult stem cells, they may not prove as helpful as ES cells. ES cells have the potential for universal application, but this may not be realized. As stated earlier, establishing ES cell lines requires destruction of human embryos. An ethical quagmire is unavoidable.

Whereas adult stem cells can be coaxed into producing the needed cells by proximity to the right tissue, the cues needed to get ES cells to produce the desired cells is not known yet. Some in the biotech industry estimate that we may be twenty years away from developing commercially available treatments using ES cells.{3} Clinical trials using adult stem cells in humans are already under way.

In August of 2000, NIH announced new guidelines allowing federally funded researchers access to human ES cell lines produced through private funding. The Clinton administration hailed the new guidelines, but Congressional pro-life advocates vowed a legal confrontation claiming the new guidelines were illegal.

The Options for President Bush

This was the situation facing President Bush when he took office. The pressure to open up federally funded human ES cell research mounted from patient advocacy groups for diabetes, spinal chord injuries, Parkinson’s disease, and Alzheimer’s. Additional pressure to reject federal funding of human ES cell research came from traditional pro-life groups including National Right to Life and the Catholic Church, with personal lobbying from Pope John Paul II.

One option open to the President and advocated by the scientific community was to free up all research avenues to fully explore all possibilities from ES cells regardless of their source. This would include federal funding for ES cells derived from embryos specifically created for this purpose. Few openly advocated this, but the oldest fertility clinic in the U. S. (in Virginia) announced recently that they were doing just that. Few within the government or research communities offered much protest.

Another option on the opposite end of the spectrum would have been to not only prohibit all federal funding on the creation and use of ES cells, but to also propose a law which would effectively ban all such research in the U. S., regardless of the funding source. Because of my view of the sanctity of human life from the moment of conception, this would be the ideal solution. However, this is not practical, since Roe v. Wade still is the rule of law in the U. S. This means that by law, a mother can choose to do with her embryo whatever she wants. If she wishes to end its life by abortion or by donation for research as a source of ES cells, she is free to do so.

A third option open to the President, and the one advocated by most in the research community, was to open up federal funding for the use and creation of ES cells derived from leftover embryos destined for destruction at fertility clinics. Some have estimated that there are over 100,000 such embryos in frozen storage in the U. S. alone. The intent is to find some use or ascribe some value to these leftover embryos. It is common practice in fertility clinics to fertilize 8-9 eggs at a time to hedge your bet against failure and to minimize expenses. As many as half of these embryos are left over after a successful pregnancy is achieved. These embryos are either left in frozen storage or destroyed at the request of the parents. So why not use them for research?

Other Options Available to President Bush

Advocates for ES cell research argue that if the embryos left over from infertility clinics are going to be wasted anyway, why not put them to some use and allow their lives to be spent helping to save someone else? The first mistake was to generate extra embryos without a clear intent to use all of them or give them up for adoption. Second, these tiny embryos are already of infinite value to God. We’re not going to redeem them by killing them for research. Each embryo is a unique human being with the full potential to develop into an adult. Each of us is a former embryo. We are not former sperm cells or egg cells.

Third, this is essentially using the dangerous ethical maxim that “the end justifies the means.” A noble end or purpose does not justify the crime. Just because a bank robber wants to donate all the money to charity doesn’t make the bank heist right. Nazi researchers gained valuable information through their many life- threatening experiments on Jews and other “undesirables” in the concentration camps of WWII. But most would not dignify these experiments by examining and using their findings.

A fourth option that I prefer is to close off all federal funding for human ES cell research. This would allow private dollars to fund human ES cell research, and federal dollars can be used to vigorously pursue the ethically preferable alternative offered by adult stem cells, which have shown great promise of late.

This would undoubtedly slow the progress on human ES cells and some researchers. Because of their dependence on federal research grants, they would not be able to pursue this line of research. But nowhere is it written that scientists have a right to pursue whatever research goals they conceive as long as they see a benefit to it. For years the U. S. Congress passed the Hyde Amendment that prohibited the use of federal funds for abortions, even though abortions were legal. The creation of human ES cells may be legal in the U. S. but that doesn’t mean researchers have a right to government monies to do so.

The President did decide to allow the use of federal funds only for research involving the 60 already existing human ES cell lines. The President expressly prohibited the use of government dollars to create new ES cell lines, even from leftover embryos. Researchers and patient advocates are unhappy, because this will limit the available research if these already existing ES cell lines don’t work out. Pro-life groups are unhappy, because the decision implicitly approves of the destruction of the embryos used to create these ES cell lines.

Stem Cells in the News Since the President’s Decision

When the President decided to open up federal funding for research on already existing human embryonic stem cell lines, just about everybody was unhappy. Researchers and patient advocates were unhappy, because this will limit the available research if these already existing cell lines don’t work out. The supply just might not meet the research demand. Pro-life groups were unhappy, including myself, because the decision implicitly approves of the destruction of the embryos used to create these ES cell lines. They will cost researchers at least $5,000 per cell line. Therefore, to purchase them for research indirectly supports their creation. Since both sides are unhappy, it was probably a good political decision even if it was not the right decision.

We certainly haven’t heard the end of this debate. Members of Congress are already positioning to strengthen or weaken the ban by law. Either way, the policy of the United States has clearly stated that innocent human life can be sacrificed without its consent, if the common good is deemed significant enough to warrant its destruction. I fully believe that this is a dangerous precedent that we will come to regret, if not now, then decades into the future. The long predicted ethical slippery slope from the abortion decision continues to threaten and gobble up the weak, the voiceless, and the defenseless of our society.

What has alarmed me the most since the President’s decision is the full assault in the media by scientists to gain even greater access to more human embryonic stem cells, regardless of how they are produced. The ethical question virtually dropped from the radar screen as scientists debated whether the existing cell lines would be enough.

This attitude is reflected in the increasing attention given to potential benefits, while downplaying the setbacks and problems. The scientists speaking through the media emphasize the new therapies as if they are only a few years down the road. The more likely scenario is that they are decades away. Your grandmother isn’t likely to be helped by this research.

Virtually nobody knows about the failure of human fetal cells to reverse the effects of Parkinson’s disease in adults. About 15 percent of patients from a recent trial were left with uncontrollable writhing and jerking movements that appear irreversible. The others in the study weren’t helped at all.{4} Chinese scientists implanted human embryonic stem cells into a suffering Parkinson’s patient’s brain only to have them transform into a powerful tumor that eventually killed him.{5}

Research with mouse embryonic stem cells has not faired much better. Scientists from the University of Wisconsin recently announced success in tricking human embryonic stem cells into forming blood cell-producing stem cells. Enthusiastic claims of future therapies overshadowed the reality that the same procedure has been successful in mice, except that when these cells are transplanted into mice, nothing happens. They don’t start producing blood cells and nobody knows why.{6}

This debate will continue. Stay tuned.

Notes

1. H. M. Blau, T. R. Brazelton, and J. M. Weiman, 2001, “The evolving concept of a stem cell:entity or function,” Cell Vol. 105 (June 29, 2001), p. 829-841.

2. James A. Thomson, et al., 1998, “Embryonic stem cell lines derived from human blastocysts.” Science Vol. 282 (November 6, 1998): 1145-1147. Also in same issue see Perspective article by John Gearhart, “New potential for human embryonic stem cells,” p. 1061-1062.

3. David Hamilton and Antonio Regaldo, 2001, “Biotech industry – unfettered, but possibly unfilfulled,” Wall Street Journal, August 13, 2001, p. B1.

4. Tracy Maddox, 2001, Fetal tissue fails to cure Parkinson’s patients. www.pointofview.net/ar_fetal.html. 3/21/01.

5. Charles Krauthammer, 2001, “The great stem cell hoax,” The Weekly Standard, August 20/August 27, 2001, p. 12.

6. Nicholas Wade, 2001, “Blood cells from stem cells,” Dallas Morning News, September 4, 2001, p. A1. The article was a New York Times News Service report.

© 2001 Probe Ministries